Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Nov 17;9(11):704.
doi: 10.3390/bioengineering9110704.

Intraoperative Creation of Tissue-Engineered Grafts with Minimally Manipulated Cells: New Concept of Bone Tissue Engineering In Situ

Affiliations
Review

Intraoperative Creation of Tissue-Engineered Grafts with Minimally Manipulated Cells: New Concept of Bone Tissue Engineering In Situ

Olga A Krasilnikova et al. Bioengineering (Basel). .

Abstract

Transfer of regenerative approaches into clinical practice is limited by strict legal regulation of in vitro expanded cells and risks associated with substantial manipulations. Isolation of cells for the enrichment of bone grafts directly in the Operating Room appears to be a promising solution for the translation of biomedical technologies into clinical practice. These intraoperative approaches could be generally characterized as a joint concept of tissue engineering in situ. Our review covers techniques of intraoperative cell isolation and seeding for the creation of tissue-engineered grafts in situ, that is, directly in the Operating Room. Up-to-date, the clinical use of tissue-engineered grafts created in vitro remains a highly inaccessible option. Fortunately, intraoperative tissue engineering in situ is already available for patients who need advanced treatment modalities.

Keywords: bone repair; cell therapy; in situ; minimally manipulated cells; stem cells; surgery; tissue engineering.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
New concept of tissue engineering in situ: intraoperative isolation of cells with minimal manipulation, cell seeding on scaffold and implantation during the same surgical procedure. Created with BioRender.com.
Figure 2
Figure 2
(a) Scaffold types for bone tissue engineering in situ. (b) Methods for physical modification of scaffolds immediately in the Operating Room. Created with BioRender.com.

References

    1. Gardner J., Faulkner A., Mahalatchimy A., Webster A. Are there specific translational challenges in regenerative medicine? Lessons from other fields. Regen. Med. 2015;10:885–895. doi: 10.2217/rme.15.50. - DOI - PubMed
    1. Qiu T., Hanna E., Dabbous M., Borislav B., Toumi M. Regenerative medicine regulatory policies: A systematic review and international comparison. Health Policy. 2020;124:701–713. doi: 10.1016/j.healthpol.2020.05.004. - DOI - PubMed
    1. Yamada S., Behfar A., Terzic A. Regenerative medicine clinical readiness. Regen. Med. 2021;16:309–322. doi: 10.2217/rme-2020-0178. - DOI - PMC - PubMed
    1. Du F., Wu H., Li H., Cai L., Wang Q., Liu X., Xiao R., Yin N., Cao Y. Bone marrow mononuclear cells combined with beta-tricalcium phosphate granules for alveolar cleft repair: A 12-month clinical study. Sci. Rep. 2017;7:13773. doi: 10.1038/s41598-017-12602-1. - DOI - PMC - PubMed
    1. Sengupta D., Waldman S.D., Li S. From in vitro to in situ tissue engineering. Ann. Biomed. Eng. 2014;42:1537–1545. doi: 10.1007/s10439-014-1022-8. - DOI - PubMed

LinkOut - more resources